GSK2330672; linerixibat
Detail Product
Tags Product
| Mezinahiya pakêtê | Berdestbûnî | Biha (USD) |
| 0.1G | Ez bêzarim | 570 |
| 0.5G | Ez bêzarim | 980 |
| 1G | Ez bêzarim | 1320 |
Navê Kîmyayî:
Pentanedioic acid, 3-((((3R,5R)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-fenyl-1,4- benzothiazepin-8-yl)methyl)amino)-
Koda SMILES:
O=C(O)CC(NCC1=C(OC)C=C(C2=C1)[C@@H](C3=CC=CC=C3)N[C@](CC)(CCCC)CS2( =O)=O)CC(O)=O
Koda InChi:
InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15- 26 (33) 34) 23 (37-3) 16-22 (24) 2 7(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2, 1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
Bişkojka InChi:
CZGVOBIGEBDYTP-VSGBNLITSA-N
Keyword:
1345982-69-5;CAS:1345982-69-5;CAS:1345982-69-5;GSK-2330672; GSK 2330672; GSK2330672; linerixibat
Çareserî:Di DMSO de çareser dibe
Embarkirinî:Hişk, tarî û di 0 - 4 C de ji bo demek kurt (roj heta hefte) an -20 C ji bo demek dirêj (mehan heta salan).
Terîf:
Linerixibat (GSK2330672) înhîbîtorek pir bikêrhatî, nexwesker, û bi devkî veguhezkarê asîda bîle ya girêdayî sodyûmê (ASBT) ye.
Armanc: ASBT



![(2s,4s)-2-(3-((3-chloro-4-methylbenzyl)oxy)azetidine-1-carbonyl)-7-oxa-5-azaspiro[3.4]octan-6-one](http://www.caerulumpharm.com/uploads/微信截图_202208031320551.png)
![4H-1,3-Dioxolo[4,5-c]pirrole-4-karboksamîd, N-(3-chloro-4-fluorofenyl) tetrahydro-N,2,2-trimethyl-6-oxo-, (3aS,4S ,6aS)-](http://www.caerulumpharm.com/uploads/20240605095550.jpg)


